Nicholas A Everett
Overview
Explore the profile of Nicholas A Everett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raymond J, Athanasopoulos A, Athanasoupoulis A, Badolato C, Badolato C, Doolan T, et al.
Pharmacol Biochem Behav
. 2024 Dec;
248:173952.
PMID: 39719161
Medications to treat substance use disorders (SUDs) remain suboptimal or, in the case of stimulants and cannabis, non-existent. Many factors have contributed to this paucity, including the biological complexity of...
2.
Raymond J, Rehn S, James M, Everett N, Bowen M
Biol Sex Differ
. 2024 Jul;
15(1):57.
PMID: 39030614
Background: Social behaviour plays a key role in mental health and wellbeing, and developing greater understanding of mechanisms underlying social interaction-particularly social motivation-holds substantial transdiagnostic impact. Common rodent behavioural assays...
3.
Scicluna R, Everett N, Badolato C, Wilson B, Bowen M
Psychopharmacology (Berl)
. 2024 May;
241(8):1719.
PMID: 38709276
No abstract available.
4.
Costa P, Everett N, Turner A, Umpierrez L, Baracz S, Cornish J
Psychopharmacology (Berl)
. 2024 May;
241(8):1539-1554.
PMID: 38705893
Rationale: Alcopop beverages are generally the first alcoholic beverage that young females drink which contain high levels of sugar and alcohol. The over-consumption of these drinks may encourage alcohol co-administration...
5.
Scicluna R, Everett N, Badolato C, Wilson B, Bowen M
Psychopharmacology (Berl)
. 2024 Apr;
241(8):1705-1717.
PMID: 38676755
Rationale/objectives: Targeting cannabinoid receptor type 1 (CB1R) has shown promise for treating opioid withdrawal symptoms. This study aimed to investigate the efficacy of a specific CB1R negative allosteric modulator (NAM),...
6.
Carey H, Pegios M, Martin L, Saleeba C, Turner A, Everett N, et al.
Nat Commun
. 2023 Sep;
14(1):5884.
PMID: 37735467
Registration of data to a common frame of reference is an essential step in the analysis and integration of diverse neuroscientific data. To this end, volumetric brain atlases enable histological...
7.
Raymond J, Everett N, Gururajan A, Bowen M
Sleep
. 2023 Apr;
46(7).
PMID: 37039749
Study Objectives: Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioral processes, including sleep and wakefulness. Since oxytocin can enhance attention to social and fear-related environmental cues,...
8.
Robinson K, Everett N, Baracz S, Cornish J
Psychopharmacology (Berl)
. 2022 Aug;
239(9):2903-2919.
PMID: 35920922
Introduction: Methamphetamine (METH, "ice") is a potent and addictive psychostimulant. Abuse of METH perturbs neurotransmitter systems and induces neurotoxicity; however, the neurobiological mechanisms which underlie addiction to METH are not...
9.
Baracz S, Robinson K, Wright A, Turner A, McGregor I, Cornish J, et al.
Neuropsychopharmacology
. 2022 May;
47(8):1561-1573.
PMID: 35581382
Early life stress (ELS) is associated with perturbed neural development and augmented vulnerability to mental health disorders, including addiction. How ELS changes the brain to increase addiction risk is poorly...
10.
Umpierrez L, Costa P, Michelutti E, Baracz S, Sauer M, Turner A, et al.
Psychopharmacology (Berl)
. 2022 Apr;
239(5):1593-1603.
PMID: 35435462
Rationale: Cannabidiol (CBD) and cannabidiolic acid (CBDA) are non-psychoactive components of the cannabis plant. CBD has been well characterised to have anxiolytic and anticonvulsant activity, whereas the behavioural effects of...